Diagnostic Performance of Serum Biomarkers Fibroblast Growth Factor 21, Galectin-3 and Copeptin for Heart Failure with Preserved Ejection Fraction in a Sample of Patients with Type 2 Diabetes Mellitus

More than half of the patients with heart failure have preserved ejection fraction (HFpEF), however evidence shows a mortality rate comparable to those with reduced ejection fraction. The aim of this study was to evaluate whether FGF21, galectin-3 and copeptin can be used as biomarkers to identify H...

Descripción completa

Detalles Bibliográficos
Autores principales: Ianoș, Raluca D., Pop, Călin, Iancu, Mihaela, Rahaian, Rodica, Cozma, Angela, Procopciuc, Lucia M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8470703/
https://www.ncbi.nlm.nih.gov/pubmed/34573919
http://dx.doi.org/10.3390/diagnostics11091577

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8470703/
https://www.ncbi.nlm.nih.gov/pubmed/34573919
http://dx.doi.org/10.3390/diagnostics11091577

Ejemplares similares